omega-n-methylarginine has been researched along with chloroquine in 3 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (chloroquine) | Trials (chloroquine) | Recent Studies (post-2010) (chloroquine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 16,405 | 763 | 4,029 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | chloroquine (IC50) |
|---|---|---|---|
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 43 | |
| Spike glycoprotein | Betacoronavirus England 1 | 5.47 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 5.47 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 5.47 | |
| Dihydrofolate reductase | Bos taurus (cattle) | 0.0301 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 7 | |
| Histidine-rich protein PFHRP-II | Plasmodium falciparum (malaria parasite P. falciparum) | 0.2383 | |
| Procathepsin L | Homo sapiens (human) | 5.47 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 5.47 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Spike glycoprotein | Severe acute respiratory syndrome coronavirus 2 | 3.58 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.375 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 1.5 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.27 | |
| Beta-secretase 1 | Homo sapiens (human) | 7 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 5.47 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.503 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 6.235 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.02 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Deguchi, J; Ekasari, W; Hirasawa, Y; Honda, T; Hosoya, T; Ishikawa, T; Kamata, K; Matsumoto, T; Morita, H; Tomizawa, Y; Wahyuni, TS; Widyawaruyanti, A; Zaima, K; Zaini, NC | 1 |
| Bienzle, U; Chaves, MF; Kremsner, PG; Neifer, S; Rudolph, R | 1 |
| Abiose, AK; Blaschke, TF; Grossmann, M; Hoffman, BB; Tangphao, O | 1 |
3 other study(ies) available for omega-n-methylarginine and chloroquine
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of cassiarin A as potential antimalarials with vasorelaxant activity.
Topics: Animals; Antimalarials; Binding, Competitive; Cell Adhesion Molecules; Cell Separation; Endothelial Cells; Endothelium; Heterocyclic Compounds, 3-Ring; Malaria, Falciparum; Microcirculation; Molecular Structure; Nitric Oxide; Parasitic Sensitivity Tests; Plasmodium falciparum; Rats; Structure-Activity Relationship; Vasodilation | 2009 |
Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine.
Topics: Animals; Arginine; Chloroquine; Deferoxamine; Female; Immunization; Interferon-gamma; Liver; Malaria; Mice; Mice, Inbred BALB C; omega-N-Methylarginine; Pentoxifylline; Tumor Necrosis Factor-alpha | 1992 |
Chloroquine-induced venodilation in human hand veins.
Topics: Adult; Antimalarials; Antirheumatic Agents; Chloroquine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hand; Histamine; Histamine Antagonists; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Vasodilation; Veins | 1997 |